GPT and osteosarcoma: Taken together, our findings indicate that the downregulation of LAP2α may be associated with the aggressive behavior of ALT-positive osteosarcoma, suggesting its potential as a marker or therapeutic target, although further studies are necessary to confirm its clinical relevance.